Skip to content
OpenCapital
Get started

Tandem Diabetes Care TNDM EBITDA

EBITDA at other companies

AdaptHealth logo
AdaptHealthAHCO
$111.96M-4.7%
Mannkind logo
MannkindMNKD
$4.72M-80.7%
Omnicell logo
OmnicellOMCL
$35.43M+323%
Insulet logo
InsuletPODD
——
Medtronic logo
MedtronicMDT
——
Abbott logo
AbbottABT
——

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.03B-23.6%
Enterprise value$1.58B-11.3%
P/S1×-0.4×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Calculated from Tandem Diabetes Care’s reported figures.

−$17.4Mebit+
$4.5MDepreciation Depletion & Amortization
=-$12.93M

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's EBITDA?
Tandem Diabetes Care (TNDM) reported EBITDA of -$12.93M in Q1 2026.
How has Tandem Diabetes Care's EBITDA changed year-over-year?
Tandem Diabetes Care's EBITDA increased by 88.9% year-over-year, from -$116.57M to -$12.93M.
What is the long-term trend for Tandem Diabetes Care's EBITDA?
Over 4 years (2021 to 2025), Tandem Diabetes Care's EBITDA has grown at a 46.8% compound annual growth rate (CAGR), from $36.5M to -$169.59M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.